Role of interlekin-35 as a biomarker in patients with newly diagnosed Hashimoto’s thyroiditis Cover

.blurhash-client-img { display: none !important; }

Role of interlekin-35 as a biomarker in patients with newly diagnosed Hashimoto’s thyroiditis

Endocrine Regulations

Volume 50 (2016): Issue 2 (April 2016)

By: Hakki Yilmaz, M. Cakmak, B. Ceydilek, C. Demir and A. Aktas

Open Access

|May 2016

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.1515/enr-2016-0009 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668

Journal RSS Feed

Language: English

Page range: 55 - 61

Published on: May 18, 2016

Published by: Slovak Academy of Sciences, Mathematical Institute

In partnership with: Paradigm Publishing Services

Publication frequency: 1 issue per year

Keywords:

Hashimoto’s thyroiditis,

hypothyroidism,

Related subjects:

Molecular biology,

Basic medical science,

Basic medical science, other,

Clinical medicine,

Internal medicine,

Endocrinology, diabetology

© 2016 Hakki Yilmaz, M. Cakmak, B. Ceydilek, C. Demir, A. Aktas, published by Slovak Academy of Sciences, Mathematical Institute
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 50 (2016): Issue 2 (April 2016)Next article